Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert J Burckart

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
JAMA Pediatrics|August 8, 2013
Adolescent dosing and labeling since the Food and Drug Administration Amendments Act of 2007Jeremiah D Momper, Yeruk Mulugeta, Dionna J Green, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2003
Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphismsHongXia Zheng, Steven Webber, Adriana Zeevi, et al.
Clinical Therapeutics|July 2, 2016
Exposure Matching of Pediatric Anti-infective Drugs: Review of Drugs Submitted to the Food and Drug Administration for Pediatric ApprovalKanecia Zimmerman, Martin Putera, Christoph P Hornik, et al.
Journal of Clinical Pharmacology|January 20, 2018
Obesity and Pediatric Drug DevelopmentJanelle D Vaughns, Laurie S Conklin, Ying Long, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|August 23, 2021
Fusion Oncoproteins in Childhood Cancers: Potential Role in Targeted TherapySara D A Angione, Alemayehu Y Akalu, Jessica Gartrell, et al.
Transplant Immunology|January 25, 2006
Impact of ABCB1 (MDR1) haplotypes on tacrolimus dosing in adult lung transplant patients who are CYP3A5 *3/*3 non-expressorsJian Wang, Adriana Zeevi, Kenneth McCurry, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|July 26, 2016
Prediction of Warfarin Dose in Pediatric Patients: An Evaluation of the Predictive Performance of Several ModelsElizabeth Marek, Jeremiah D Momper, Ronald N Hines, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Adverse Event Detection and Labeling in Pediatric Drug Development: Antiretroviral DrugsJeremiah D Momper, Yang Chang, Matthew Jackson, et al.
Clinical Pharmacology and Therapeutics|August 11, 2018
Surrogate Endpoints in Pediatric Studies Submitted to the US FDADionna J Green, Haihao Sun, Janelle Burnham, et al.
Journal of Clinical Pharmacology|August 15, 2022
Extrapolation of Adult Efficacy Data to Pediatric Systemic Lupus Erythematosus: Evaluating Similarities in Exposure-ResponseStephen J Balevic, Jing Niu, Jianmeng Chen, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
JAMA Pediatrics|August 8, 2013
Adolescent dosing and labeling since the Food and Drug Administration Amendments Act of 2007Jeremiah D Momper, Yeruk Mulugeta, Dionna J Green, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2003
Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphismsHongXia Zheng, Steven Webber, Adriana Zeevi, et al.
Clinical Therapeutics|July 2, 2016
Exposure Matching of Pediatric Anti-infective Drugs: Review of Drugs Submitted to the Food and Drug Administration for Pediatric ApprovalKanecia Zimmerman, Martin Putera, Christoph P Hornik, et al.
Journal of Clinical Pharmacology|January 20, 2018
Obesity and Pediatric Drug DevelopmentJanelle D Vaughns, Laurie S Conklin, Ying Long, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|August 23, 2021
Fusion Oncoproteins in Childhood Cancers: Potential Role in Targeted TherapySara D A Angione, Alemayehu Y Akalu, Jessica Gartrell, et al.
Transplant Immunology|January 25, 2006
Impact of ABCB1 (MDR1) haplotypes on tacrolimus dosing in adult lung transplant patients who are CYP3A5 *3/*3 non-expressorsJian Wang, Adriana Zeevi, Kenneth McCurry, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|July 26, 2016
Prediction of Warfarin Dose in Pediatric Patients: An Evaluation of the Predictive Performance of Several ModelsElizabeth Marek, Jeremiah D Momper, Ronald N Hines, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Adverse Event Detection and Labeling in Pediatric Drug Development: Antiretroviral DrugsJeremiah D Momper, Yang Chang, Matthew Jackson, et al.
Clinical Pharmacology and Therapeutics|August 11, 2018
Surrogate Endpoints in Pediatric Studies Submitted to the US FDADionna J Green, Haihao Sun, Janelle Burnham, et al.
Journal of Clinical Pharmacology|August 15, 2022
Extrapolation of Adult Efficacy Data to Pediatric Systemic Lupus Erythematosus: Evaluating Similarities in Exposure-ResponseStephen J Balevic, Jing Niu, Jianmeng Chen, et al.
Pageof 13